​

Funding Round

Series A - Code Biotherapeutics

Series A - Code Biotherapeutics

Investment Firm

Overview

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.

Announced Date

Jun 07, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

8

Investor Name
Participant InvestorAmgen Ventures
Participant InvestorJDRF T1D Fund
Participant Investor4BIO Capital
Participant InvestorHatteras Venture Partners
Participant InvestorNew Enterprise Associates

Round Details and Background

Code Biotherapeutics raised $75000000 on 2022-06-07 in Series A

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 20, 2021
Seed Round - Code Biotherapeutics
6-10.0M
Jun 07, 2022
Series A - Code Biotherapeutics
10-75.0M

Recent Activity

There is no recent news or activity for this profile.